跳到正文
原文
Nature 健康护理主题·· 2026-10-17AI 评分41

系统综述与Meta分析:男性伴侣治疗对减少细菌性阴道炎复发的有效性

Effectiveness of male partner treatment in reducing recurrence of bacterial vaginosis: a systematic review and meta-analysis

AI 导读

针对 heterosexual 夫妇的系统综述与Meta分析显示,单纯口服的男性伴侣治疗并未显著降低细菌性阴道炎的复发率(合并OR 0.90,95% CI 0.57–1.40)。该研究不推荐常规使用单纯口服方案,但单一试验表明联合口服和局部治疗可显著降低复发(OR 0.31),且伴侣接受度良好。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Bacterial vaginosis frequently recurs after standard antimicrobial therapy, and reinfection from untreated male partners may contribute to recurrence. We systematically reviewed studies comparing male partner treatment with placebo or no partner treatment in heterosexual couples. Of the 11 included studies, six randomised controlled trials contributed to the meta-analysis. At 4–5 weeks, all evaluable trials assessed oral-only male partner treatment, which was not associated with a significant reduction in recurrence (pooled OR 0.90, 95% CI 0.57–1.40; P = 0.63). Because trials evaluating oral-only and combined oral-topical regimens at 12–16 weeks were clinically and pharmacologically distinct, these were analysed separately: oral-only male partner treatment showed no significant benefit (pooled OR 1.17, 95% CI 0.78–1.77), whereas the single trial evaluating a combined regimen reported a significant reduction in recurrence (OR 0.31, 95% CI 0.15–0.62). Five additional studies were synthesised narratively, with qualitative findings suggesting good partner acceptability. These findings do not support routine oral-only male partner treatment. However, emerging evidence indicates that combined oral and topical treatment, targeting both urethral and penile-skin reservoirs, may substantially reduce recurrence. This distinction is biologically plausible, acceptable to couples, and clinically relevant, particularly as several guideline bodies have recently endorsed combined-regimen partner therapy. Future recommendations should differentiate regimen type, recurrence risk, and implementation feasibility rather than applying male partner treatment as a single intervention.

Trial registration: PROSPERO number CRD420251111546.

Funding

This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Gynecology, Obstetrics and Gynecological Endocrinology, Medical Faculty, Kepler University Hospital, Johannes Kepler University, Linz, Austria

    Jeannine Metz

  2. Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria

    Alex Farr, Herbert Kiss, Arlena Witt, Florian Heinzl & Philipp Foessleitner

  3. Das Deutsche Zentrum für Infektionen in Gynäkologie und Geburtshilfe, Landesfrauenklinik Helios Universitätsklinikum Wuppertal - University Witten/Herdecke, Wuppertal, Germany

    Werner Mendling

  4. Vincent Center for Reproductive Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Caroline Mitchell

Authors

  1. Jeannine Metz
  2. Alex Farr
  3. Herbert Kiss
  4. Arlena Witt
  5. Florian Heinzl
  6. Werner Mendling
  7. Caroline Mitchell
  8. Philipp Foessleitner

Corresponding author

Correspondence to Philipp Foessleitner.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

Ethical approval was not required. This study is a systematic review of published literature.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Metz, J., Farr, A., Kiss, H. et al. Effectiveness of male partner treatment in reducing recurrence of bacterial vaginosis: a systematic review and meta-analysis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-75470-8

Download citation

  • Received: 02 July 2026

  • Accepted: 07 October 2026

  • Published: 17 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-75470-8

Keywords

来源:Nature 健康护理主题 · nature.com